Erratum: fMiRNA-192 and miRNA-204 Directly Suppress lncRNA HOTTIP and Interrupt GLS1-Mediated Glutaminolysis in Hepatocellular Carcinoma (PLoS Genet (2015) 11:12 (e1005726) DOI: 10.1371/journal.pgen.1005726);fMiRNA-192 and miRNA-204 Directly Suppress lncRNA HOTTIP and Interrupt GLS1-Mediated Glutaminolysis in Hepatocellular Carcinoma

PLoS Genetics

Volumn 11, Issue 12, 2015, Pages

  Ge, Yunxia ^a   Yan, Xiaodan ^a   Jin, Yiguang ^b   Yang, Xinyu ^a   Yu, Xiang ^b   Zhou, Liqing ^c   Han, Sichong ^a   Yuan, Qipeng ^a   Yang, Ming ^a  

^a BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c Huaian No 2 Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE 2 PROTEIN; GLUTAMINASE; HOTTIP PROTEIN; LONG UNTRANSLATED RNA; LUCIFERASE; MICRORNA; MICRORNA 192; MICRORNA 204; PROTEIN; RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXA; TRANSCRIPTION FACTOR HOXA 13; UNCLASSIFIED DRUG; ARGONAUTE PROTEIN; EIF2C2 PROTEIN, HUMAN; GLS1 PROTEIN, HUMAN; MIRN192 MICRORNA, HUMAN; MIRN204 MICRORNA, HUMAN;

ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CELL; LIVER CELL CARCINOMA; ONCOGENE; OVERALL SURVIVAL; POSTTRANSCRIPTIONAL GENE SILENCING; PROTEIN EXPRESSION; REPORTER GENE; RNA INTERFERENCE; TUMOR XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; FEMALE; GENETICS; HEP-G2 CELL LINE; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; MOUSE; NUDE MOUSE; PATHOLOGY;

ANIMALS; ARGONAUTE PROTEINS; CARCINOMA, HEPATOCELLULAR; FEMALE; GLUTAMINASE; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; RNA, LONG NONCODING;

EID: 84953291614     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/JOURNAL.PGEN.1005825     Document Type: Erratum

References (55)

1. Parkin DM, Bray F, Ferlay J, Pisani P, Global cancer statistics, 2002.CA Cancer J Clin 2005;55:74–108. 15761078
2. El-Serag HB, Rudolph KL, Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557–2576. 17570226
3. Cech TR, Steitz JA, The noncoding RNA revolution-trashing old rules to forge new ones.Cell 2014;157:77–94. doi: 10.1016/j.cell.2014.03.008 24679528
4. Lee JT, Epigenetic regulation by long noncoding RNAs. Science 2012;338:1435–1439. doi: 10.1126/science.1231776 23239728
5. Nagano T, Fraser P, No-nonsense functions for long noncoding RNAs. Cell 2011;145:178–181. doi: 10.1016/j.cell.2011.03.014 21496640
6. Quagliata L, Matter MS, Piscuoglio S, Arabi L, Ruiz C, Procino A, et al. Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Hepatology 2014;59:911–923. doi: 10.1002/hep.26740 24114970
7. Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y, et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res 2010;38:5366–5383. doi: 10.1093/nar/gkq285 20423907
8. Du Y, Kong G, You X, Zhang S, Zhang T, Gao Y, et al. Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem 2012;287:26302–26311. doi: 10.1074/jbc.M112.342113 22685290
9. Hämmerle M, Gutschner T, Uckelmann H, Ozgur S, Fiskin E, Gross M, et al. Posttranscriptional destabilization of the liver-specific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1). Hepatology 2013;58:1703–1712. doi: 10.1002/hep.26537 23728852
10. Yang Z, Zhou L, Wu LM, Lai MC, Xie HY, Zhang F, et al. Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation.Ann Surg Oncol 2011;18:1243–1250. doi: 10.1245/s10434-011-1581-y 21327457
11. Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY, Zhang FW, et al. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation.Med Oncol 2012;29:1810–1816. doi: 10.1007/s12032-011-0004-z 21678027
12. Yang F, Zhang L, Huo XS, Yuan JH, Xu D, Yuan SX, et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology2011;54:1679–1689. doi: 10.1002/hep.24563 21769904
13. Lau CC, Sun T, Ching AK, He M, Li JW, Wong AM, et al. Viral-human chimeric transcript predisposes risk to liver cancer development and progression.Cancer Cell 2014;25:335–349. doi: 10.1016/j.ccr.2014.01.030 24582836
14. Wang F, Yuan JH, Wang SB, Yang F, Yuan SX, Ye C, et al. Oncofetal Long Noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2. Hepatology 2014;60:1278–1290. doi: 10.1002/hep.27239 25043274
15. Yoshimizu T, Miroglio A, Ripoche MA, Gabory A, Vernucci M, Riccio A, et al. The H19 locus acts in vivo as a tumor suppressor. Proc Natl Acad Sci USA 2008;105:12417–12422. doi: 10.1073/pnas.0801540105 18719115
16. Braconi C, Kogure T, Valeri N, Huang N, Nuovo G, Costinean S, et al.MicroRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer.Oncogene 2011;30:4750–4756. doi: 10.1038/onc.2011.193 21625215
17. Huang JF, Guo YJ, Zhao CX, Yuan SX, Wang Y, Tang GN, et al. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin. Hepatology 2013;57:1882–1892. doi: 10.1002/hep.26195 23239537
18. Yang F, Huo XS, Yuan SX, Zhang L, Zhou WP, Wang F, et al. Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol Cell 2013;49:1083–1096. doi: 10.1016/j.molcel.2013.01.010 23395002
19. Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ, Tao QF, et al. A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma.Cancer Cell2014;25:666–681. doi: 10.1016/j.ccr.2014.03.010 24768205
20. Yuan SX, Yang F, Yang Y, Tao QF, Zhang J, Huang G, et al. Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy. Hepatology 2012;56:2231–2241. doi: 10.1002/hep.25895 22706893
21. Wang KC, Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y, et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression.Nature 2011;472:120–124. doi: 10.1038/nature09819 21423168
22. Liu Q, Huang J, Zhou N, Zhang Z, Zhang A, Lu Z, et al. LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res 2013;41:4976–4987. doi: 10.1093/nar/gkt182 23558749
23. Zhang Z, Zhu Z, Watabe K, Zhang X, Bai C, Xu M, et al. Negative regulation of lncRNA GAS5 by miR-21. Cell Death Differ 2013;20:1558–1568. doi: 10.1038/cdd.2013.110 23933812
24. Jeggari A, Marks DS, Larsson E, MiRcode: a map of putative microRNA target sites in the long non-coding transcriptome. Bioinformatics 2012;28:2062–2063. doi: 10.1093/bioinformatics/bts344 22718787
25. Ambros V, MicroRNAs: tiny regulators with great potential.Cell 2001;107:823–826. 11779458
26. Bartel DP, MicroRNAs: genomics, biogenesis, mechanism, and function.Cell 2004;116:281–297. 14744438
27. Gu S, Jin L, Zhang F, Sarnow P, Kay MA, Biological basis for restriction of microRNA targets to the 3' untranslated region in mammalian mRNAs. Nat Struct Mol Biol 2009;16:144–150. doi: 10.1038/nsmb.1552 19182800
28. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP, A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010;465:1033–1038. doi: 10.1038/nature09144 20577206
29. Chiyomaru T, Fukuhara S, Saini S, Majid S, Deng G, Shahryari V, et al. Long non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells. J Biol Chem 2014;289:12550–12565. doi: 10.1074/jbc.M113.488593 24616104
30. Braun CJ, Zhang X, Savelyeva I, Wolff S, Moll UM, Schepeler T, et al. p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. Cancer Res 2008;68:10094–10104. doi: 10.1158/0008-5472.CAN-08-1569 19074875
31. Georges SA, Biery MC, Kim SY, Schelter JM, Guo J, Chang AN, et al. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215. Cancer Res 2008;68:10105–10112. doi: 10.1158/0008-5472.CAN-08-1846 19074876
32. Song B, Wang Y, Kudo K, Gavin EJ, Xi Y, Ju J, MiR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit. Clin Cancer Res 2008;14:8080–8086. doi: 10.1158/1078-0432.CCR-08-1422 19088023
33. Boni V, Bitarte N, Cristobal I, Zarate R, Rodriguez J, Maiello E, et al.MiR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation. Mol Cancer Ther 2010;9:2265–2275. doi: 10.1158/1535-7163.MCT-10-0061 20647341
34. Feng S, Cong S, Zhang X, Bao X, Wang W, Li H, et al. MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells. Nucleic Acids Res 2011;39:6669–6678. doi: 10.1093/nar/gkr232 21511813
35. Kim T, Veronese A, Pichiorri F, Lee TJ, Jeon YJ, Volinia S, et al. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med 2011;208:875–883. doi: 10.1084/jem.20110235 21518799
36. Geng L, Chaudhuri A, Talmon G, Wisecarver JL, Are C, Brattain M, et al. MicroRNA-192 suppresses liver metastasis of colon cancer. Oncogene 2014;33:5332–5340. doi: 10.1038/onc.2013.478 24213572
37. Zhou J, Yu L, Gao X, Hu J, Wang J, Dai Z, et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol 2011;29:4781–4788. doi: 10.1200/JCO.2011.38.2697 22105822
38. Garzon R, Garofalo M, Martelli MP, Briesewitz R, Wang L, Fernandez-Cymering C, et al. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci USA 2008;105:3945–3950. doi: 10.1073/pnas.0800135105 18308931
39. Chung TK, Lau TS, Cheung TH, Yim SF, Lo KW, Siu NS, et al. Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1. Int J Cancer 2012;130:1036–1045. doi: 10.1002/ijc.26060 21400511
40. Mikhaylova O, Stratton Y, Hall D, Kellner E, Ehmer B, Drew AF, et al. VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma. Cancer Cell 2012;21:532–546. doi: 10.1016/j.ccr.2012.02.019 22516261
41. Ryan J, Tivnan A, Fay J, Bryan K, Meehan M, Creevey L, et al. MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome. Br J Cancer 2012;107:967–976. doi: 10.1038/bjc.2012.356 22892391
42. Ying Z, Li Y, Wu J, Zhu X, Yang Y, Tian H, et al. Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype. Cancer Res 2013;73:990–999. doi: 10.1158/0008-5472.CAN-12-2895 23204229
43. Warburg O, On the origin of cancer cells.Science1956;123:309–314. 13298683
44. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB, The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008;7:11–20. doi: 10.1016/j.cmet.2007.10.002 18177721
45. Wise DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang XY, Pfeiffer HK, et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci USA 2008;105:18782–18787. doi: 10.1073/pnas.0810199105 19033189
46. Hensley CT, Wasti AT, DeBerardinis RJ, Glutamine and cancer: cell biology, physiology, and clinical opportunities. J Clin Invest 2013;123:3678–3684. doi: 10.1172/JCI69600 23999442
47. Chiu M, Tardito S, Pillozzi S, Arcangeli A, Armento A, Uggeri J, et al. Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts. Br J Cancer 2014;111:1159–1167. doi: 10.1038/bjc.2014.425 25072259
48. Gagnon KT, Li L, Chu Y, Janowski BA, Corey DR, RNAi factors are present and active in human cell nuclei. Cell Rep 2014;6:211–221. doi: 10.1016/j.celrep.2013.12.013 24388755
49. Wei Y, Li L, Wang D, Zhang CY, Zen K, Importin 8 regulates the transport of mature microRNAs into the cell nucleus. J Biol Chem 2014;289:10270–10275. doi: 10.1074/jbc.C113.541417 24596094
50. Wang X, Li M, Wang Z, Han S, Tang X, Ge Y, et al. Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells. J Biol Chem 2015;290:3925–3935. doi: 10.1074/jbc.M114.596866 25538231
51. Leucci E, Patella F, Waage J, Holmstrøm K, Lindow M, Porse B, et al. microRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus. Sci Rep 2013;3:2535. doi: 10.1038/srep02535 23985560
52. Han Y, Liu Y, Zhang H, Wang T, Diao R, Jiang Z, et al.Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1. FEBS Lett 2013;587:3875–3882. 24396870
53. Zhang X, Wei J, Zhou L, Zhou C, Shi J, Yuan Q, et al. A functional BRCA1 coding sequence genetic variant contributes to risk of esophageal squamous cell carcinoma. Carcinogenesis 2013;34:2309–2313. doi: 10.1093/carcin/bgt213 23749772
54. Liu L, Zhou C, Zhou L, Peng L, Li D, Zhang X, et al. Functional FEN1 genetic variants contribute to risk of hepatocellular carcinoma, esophageal cancer, gastric cancer and colorectal cancer. Carcinogenesis 2012;33:119–123. doi: 10.1093/carcin/bgr250 22072618
55. Zhang X, Zhou L, Fu G, Sun F, Shi J, Wei J, et al. The identification of an ESCC susceptibility SNP rs920778 that regulates the expression of lncRNA HOTAIR via a novel intronic enhancer.Carcinogenesis2014;35:2062–2067. doi: 10.1093/carcin/bgu103 24788237